TrialJournal of clinical hypertension (Greenwich, Conn.)2021

Safety and efficacy of empagliflozin in elderly Japanese patients with type 2 diabetes mellitus: A post hoc analysis of data from the SACRA study.

Kenta Okada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.